Paul Faulder

Paul Faulder is the CEO and Co-Founder of Elixir Software Ltd, a company established in 2012 that leverages over 70 years of collective industry experience to enhance drug discovery and development through collaborative efforts among pharmaceutical, biotech companies, contract research organizations, and academic laboratories. Prior to founding Elixir, Paul held positions as a Computational Chemist at AstraZeneca, where molecular design work focused on Oncology, and at GlaxoSmithKline, specializing in Inflammatory Diseases. Earlier experience includes a role at Tularik, contributing to molecular design in Inflammation and Oncology. Paul earned a Doctor of Philosophy (PhD) in Computational Chemistry from The University of Manchester.